| Literature DB >> 35049866 |
Yi Qi1,2, Jingyi Zhou1, Xiaoqin Shen3, Meram Chalamaiah4, Simin Lv5, Hui Luo1,2, Liang Chen1.
Abstract
Peanut worms (Sipunculids) are unsegmented marine worms that usually inhabit shallow waters. Peanut worms are good source of bioactive compounds including peptides and polysaccharides. Many recent studies have investigated the bioactive properties of peptides and polysaccharides derived from peanut worms in order to enhance their applications in food and pharmaceutical industries. The peptides and polysaccharides isolated from peanut worms have been reported to possess anti-hypertensive, anti-oxidant, immunomodulatory, anti-inflammatory, anti-cancer, anti-hypoxia and wound healing activities through the modulation of various molecular mechanisms. Most researchers used in vitro, cell culture and animal models for the determination of bioactivities of peanut worm derived compounds. However, studies in humans have not been performed considerably. Therefore, it is important to conduct more human studies for better utilization of marine bioactive compounds (peptides and polysaccharides) derived from peanut worms. This review mainly focuses on the bioactive properties of peptides and polysaccharides of peanut worms and their molecular mechanisms.Entities:
Keywords: bioactive properties; marine worms; peptides; polysaccharides; sipunculids
Mesh:
Substances:
Year: 2021 PMID: 35049866 PMCID: PMC8779918 DOI: 10.3390/md20010010
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Various major bioactivities of peptides and polysaccharides derived from peanut worms.
Molecular mechanisms of anti-oxidant peptides derived from peanut worms.
| Peanut Worm Name | Enzyme Used to Produce Peptides | Peptide Sequence and Molecular Weight | In Vitro/Cell Culture/Animals/Humans Used for the Study | Dose and Duration | Mechanism of Action/ | Ref. |
|---|---|---|---|---|---|---|
|
| Papain | Peptides 5868 Da | In vitro hydroxyl Radical scavenging activity | ------- | The polypeptide showed great hydroxyl radical scavenging activity with 95.42% inhibition. | [ |
|
| Pancreatin | Peptides < 3 kDa | Mice | 50, 100 and 150 mg/kg for 15 days | Peptides dose-dependently improved the oxidative stress status (GSH-Px, SOD, TAC andMDA) in mice | [ |
|
| Papain | ----------- | In vitro total anti-oxidant capacity | --------- | Collagen peptides from | [ |
Molecular mechanisms of anti-oxidant activities of polysaccharides derived from various peanut worms.
| Source | Composition of Polysaccharide Extract | Cell Culture/ | Dose and Duration | Molecular Mechanisms/Effects | Ref. |
|---|---|---|---|---|---|
|
| Polysaccharide was com-posed of mannose, rhamnose, galacturonic acid, glucose, arabinose and fucose | In vitro hydroxyl radical activity. | 0.25, 0.5, 1.0, 2.0, 5.0,10.0, 20.0 mg/mL for 30 min | Polysaccharide showed powerful scavenging activity on hydroxyl radical in a dose dependent manner. | [ |
|
| ----------------- | In vitro reducing power, hydroxyl and superoxide radicals inhibition assay | 200–1000 µg/mL for 30 min | [ | |
|
| D-glucosyl, D-galactosyl, with small amount of D-mannosyl, D-arabinosyl and residues with a- and b-type linkage. | Mice | 1, 10 and 5 mg/mL for 30 days | Oligosaccharides from | [ |
|
| Mannose, ribose, rhamnose, | In vitro DPPH, superoxide | 0.2, 0.4 and 0.8 g/kgBW for 25 d | Polysaccharides from | [ |
|
| ----------- | In vitro DPPH and hydroxyl radical scavenging activities | 0.2 mg/mL | Free radical scavenging rates increased significantly with the increase of concentration. The scavenging activities of hydroxyl radical and DPPH radical were found to be | [ |
|
| polysaccharide contained glucose with acetylaminoand pyran rings and connected by | In vitro reducing power, DPPH and hydroxyl radical scavenging activities | 1,5,10,15,20, and 25 mg/mL for 30 min | Polysaccharide showed DPPH and hydroxyl radical scavenging and reducing power with IC50 of 0.567 and 0.605, 2.976 mg/mL, respectively. | [ |
Molecular mechanisms of anti-inflammatory peptides derived from peanut worms.
| Peanut Worm Name | Enzyme Used to Produce Peptides | Peptide Sequence and Molecular Weight | In Vitro/Cell Culture/Animals/Humans Used for the Study | Dose and Duration | Mechanism of Action/Activities/Effects Showed | Ref. |
|---|---|---|---|---|---|---|
|
| Neutrase, Flavourzyme, and Alcalase | LSPLLAAH (821.48 Da) and TVNLAYY (843.42 Da). | RAW 264.7 macrophages | 30, 60, 120 mm for 12 h | Peptides (LSPLLAAH and TVNLAYY) inhibited NO production and decreased the expression of pro-inflammatory mediators, iNOS, IL-6, TNF-α, and COX-2, in LPS-stimulated RAW264.7 macrophages. | [ |
|
| Animal hydrolytic protease (3000 U/g) and flavor protease | Collagen peptides < 5 kDa | Mice | 2 g/mL for 7 days | Peptides showed anti-inflammatory activity through the reduction of mRNA levels of TGF-β1, TNF-α and IL-1β in the wound of mice skin. | [ |
Molecular mechanisms of anti-inflammatory activity of polysaccharides derived from various peanut worms.
| Source | Composition of Polysaccharide Extract | Cell Culture/ | Dose and Duration | Molecular Mechanisms/Effects | Ref. |
|---|---|---|---|---|---|
|
| Water extract | Mouse and rat oedema paw models | 50, 100 and 200 mg/kg for 6 days | Water extract from the body wall of | [ |
|
| D-glucosyl, D-galactosyl, with small amount of D-mannosyl, D-arabinosyl and residues with α- and β-type linkage. | Mice | 1, 10 and 5 mg/mL for 30 days | Oligosaccharides from | [ |
Molecular mechanisms of action of ACE-inhibitory/anti-hypertensive peptides derived from various peanut worms.
| Peanut Worm Name | Enzyme Employed to Produce Peptides | Peptide Sequence and Molecular Weight | In Vitro/Cell Culture/Animals/Humans Used for the Study | IC50/EC50 | Activity/Mechanisms of Action Showed | Ref. |
|---|---|---|---|---|---|---|
|
| Pepsin | AWLHPGAPKVF | In vitro ACE inhibition assay & spontaneously hypertensive rats | IC50 value of 135 M | Peptide inhibited ACE through competitive inhibition and exhibited anti-hypertensive effects in rats by significantly reducing the systolic blood pressure around 30 mmHg. | [ |
|
| Pepsin and trypsin | ---------------- | In vitro ACE inhibition assay & spontaneously hypertensive rats | IC50 values of 0.67 and 0.24 mg/mL | Peptides significantly reduced both diastolic blood pressure (DBP) and systolic blood pressure (SBP) and inhibited ACE in vitro. | [ |
|
| Pepsin, and trypsin | AYF, EL, GLR, HK, and ILK | In vitro ACE inhibition assay | IC50 values of 3.43–4.18 U/ml | Peptides exhibited ACE inhibitory activity with IC50 values in the range of 3.43–4.18 U/mL | [ |
|
| Pepsin and trypsin | 284 di- and tri-peptides | In vitro ACE inhibition assay | IC50 less than 50 μM | Peptides inhibited the ACE. | [ |
|
| Protamex | IND, VEPG, LADEF | In vitro ACE inhibition assay | IC50 values for ACE inhibition were 34.72, 20.55 and 22.77 μmol/L | The peptides IND, VEPG, and LADEF showed ACE inhibition activity with IC50 values of 34.72, 20.55 and 22.77 μmol/L, respectively. | [ |
|
| Pepsin and trypsin | RYDF, YASGR and GNGSGYVSR | In vitro ACE inhibition assay & spontaneously hypertensive rats | IC50 values of 235, 184 and 29 μM respectively for RYDF, YASGR and GNGSGYVSR | Three peptides inhibited ACE through non-competitive inhibition. GNGSGYVSR reduced systolic blood pressure 31 mmHg at 2 h after oral administration in spontaneously hypertensive rats. | [ |
|
| Pepsin and trypsin | GNGSGYV and SR | In vitro ACE inhibition assay | IC50 value of 170 μM | GNGSGYV and SR showed ACE inhibition through synergistic effect. SR initially attacked the catalytic Zn of ACE and formed coordinate bond, and then GNGSGYV attached with the residues of ACE active site by hydrogen bonds. | [ |
Molecular mechanisms of immunomodulatory activity of polysaccharides derived from peanut worms.
| Source | Composition of Polysaccharide Extract | Cell Culture/ | Dose and Duration | Molecular Mechanisms/Effects | Ref. |
|---|---|---|---|---|---|
|
| ------------ | Mice model | 3.0, 6.0, 9.0 mg/kgBW for 2 months | Polysaccharides from | [ |
|
| Monosaccharide composition -rhamnose (28%), fucose (16%) and galactose (56%) | Murine macrophages from BALB/c mice and human macrophages | 5–80 µg/mL for 24 h | The water soluble polysaccharide isolated from | [ |
|
| ------------ | Mice | ------------ | Polysaccharides from | [ |
|
| L-rhamnose, Larabinose, D-ribose, D-glucose and D-galactose | Hepatoma HepG2-bearing Mice | 50,100, and 200 mg/kg, 1 month | Polysaccharide extract from | [ |
|
| Repeating units are →3,4-β-D-GlcpNAC (1→ and →4)-α-D-Glcp (1→ in the ratio of 15:1; →2)-α-D-Galp-(1→ as a side chain; and β-D-Galp-(1→ and α-D-Glcp-(1→ as end groups | hepatoma HepG2-bearingmice | 50,100, and 200 mg/kg, 16 days | Polysaccharide increased the index of immune organs and augmented the secretion of cytokines IL-2, IFN-γ and TNF-α. | [ |
Molecular mechanisms of anti-cancer activity of polysaccharides derived from various peanut worms.
| Source | Composition of Polysaccharide Extract | Cell Culture/ | Dose and Duration | Molecular Mechanisms/Effects | Ref. |
|---|---|---|---|---|---|
|
| Extractcontains 35.3% neutral sugar, including Ara 10.7%, Rha 12.6%, Gal 16.4%, Glu 31.3%, Xyl 18.2%, and Man 10.8%. | Hepg2.2.15 cells | 0.13, 0.25, 0.5, and 1 mg/mL for 24 and 48 h | Polysaccharides showed anti-cancer activities by preventing the DNA synthesis of Hepg2.2.15 cells and increasing the expression of pro-apoptosis proteins, TNF-α, caspase-3, and Bax, and decreasing the expression of the anti-apoptosis proteins survivin, Bcl-2, and VEGF. | [ |
|
| L-rhamnose, Larabinose, D-ribose, D-glucose and D-galactose | Hepatoma HepG2-bearing Mice | 50,100, and 200 mg/kg, 1 month | Polysaccharides showed anti-tumor activity by inhibiting the growth of HepG2 cells through increase of ATF4, DDIT3, and IkBα expression and decrease of CYR61, HSP90, and VEGF expression. | [ |
|
| Repeating units of →3,4-β-D-GlcpNAC | hepatoma HepG2-bearing | 50,100, and 200 mg/kg, 16 days | Extracted polysaccharide enhanced the apoptosis of tumour cells through the mitochondrial apoptosis pathway by upregulating caspase-3, caspase-8, caspase-9 and BCL2-associated X, and downregulating B-cell lymphoma-2 and vascular endothelial growth factor protein expression. | [ |
Anti-hypoxia activity of polysaccharides derived from various peanut worms.
| Source | Composition of Polysaccharide Extract | Cell Culture/ | Dose and Duration | Molecular Mechanisms/Effects | Ref. |
|---|---|---|---|---|---|
|
| Rhamnose (28%), fucose (16%) and galactose (56%). | Mice model | 10, 30, 100 mg/kg for 6 days | The extracted polysaccharide exhibited significant anti-hypoxic activity on normobarie hypoxia, chemical intoxicant hypoxia and acute cerebral ischemia hypoxia models in mice. | [ |
Effects of peptides derived from peanut worms on wound healing and spatial learning and memory.
| Peanut Worm Name | Enzyme Used to Produce Peptides | Peptide Sequence and Molecular Weight | In Vitro/Cell Culture/Animals/Humans Used for the Study | Dose and Duration | Mechanism of Action/Activities/Effects Showed | Ref. |
|---|---|---|---|---|---|---|
|
| Animal hydrolytic protease (3000 U/g) and flavor protease | Collagen peptides < 5 kDa | human umbilical vein endothelial cells (HUVEC), human immortalized keratinocytes (HaCaT) and human skin fibroblasts (HSF) and mice | 2 g/mL for 28 days and 500 µg/mL for 12, 24, 30, 36 h | Collagen peptides derived from | [ |
|
| Pancreatin | Peptides < 3 kDa | Mice | 50, 100 and 150 mg/kg for 15 days | Peptides improved the spatial learning and memory ability doses-dependently through the up-regulation of NR2A, NR2B, BDNF and CREB mRNA expressions in hippocampus of mice. 100 mg/kg group showed better performance in spatial learning and memory compared with 50, and 150 mg/kg. | [ |